Compatibility of statutory pharmaceutical price binding with prohibition of nationality discrimination under Article 3(1) of the Basic Law
Deutschland (DE)
Legislator-Zusammenfassung
KI-generiertThe Federal Administrative Court (BVerwG) granted the plaintiff's complaint, allowing the appeal on the ground that the case possesses fundamental significance, and set a provisional amount in dispute for the revision proceedings. The dispute concerns the validity of the statutory price binding for pharmaceuticals applicable to domestic pharmacies, specifically challenging whether this regulation violates the prohibition of discrimination against German nationals in the cross-border provision of healthcare services, as established by the European Court of Justice. The decisive legal question involves the compatibility of the domestic price binding mechanism under § 78 Abs. 1 and 2 of the German Medicines Act (AMG) and § 3 of the Pharmaceuticals Pricing Regulation (AMPreisV) with Article 12(1) of the EU Charter of Fundamental Rights and Article 3(1) of the German Basic Law, following the CJEU's judgment in the Deutsche Parkinson Vereinigung case.
Legislator-Regeste
KI-generiert§ 132 Abs. 2 Nr. 1 VwGO, Art. 3 Abs. 1 GG, § 63 Abs. 1 Satz 1 GKG, § 47 Abs. 1, § 52 Abs. 2 und § 63 Abs. 1 Satz 1 GKG; Compatibility of statutory pharmaceutical price binding with prohibition of nationality discrimination under Article 3(1) of the Basic Law: The dispute concerns the validity of the statutory price binding for pharmaceuticals applicable to domestic pharmacies, specifically challenging whether this regulation violates the prohibition of discrimination against German nationals in the cross-border provision of healthcare services, as established by the European Court of Justice. The decisive legal question involves the compatibility of the domestic price binding mechanism under § 78 Abs. 1 and 2 of the German Medicines Act (AMG) and § 3 of the Pharmaceuticals Pricing Regulation (AMPreisV) with Article 12(1) of the EU Charter of Fundamental Rights and Article 3(1) of the German Basic Law, following the CJEU's judgment in the Deutsche Parkinson Vereinigung case.
Schlagwörter
KI-generiertZitierte Gesetzesbestimmungen
KI-generiertVerwandte Entscheide
KI-generiertZentrale Rechtsfragen, extrahiert von Legislator
KI-generiertThe legal basis for granting the complaint and allowing the appeal due to the fundamental significance of the case.
The procedural rules applied to determine the provisional amount in dispute for the revision proceedings.
Volltext
Revisionszulassung; Inländerdiskriminierung; zur Preisbindung von Arzneimitteln für inländische Apotheken
[GRUENDE]
Die Beschwerde der Klägerin hat Erfolg. Der Rechtssache kommt die geltend gemachte grundsätzliche Bedeutung (§ 132 Abs. 2 Nr. 1 VwGO) zu. Das Revisionsverfahren wird dem Bundesverwaltungsgericht voraussichtlich Gelegenheit zur Klärung der Frage geben, ob die für inländische Apotheken geltende Preisbindung für Arzneimittel (§ 78 Abs. 1 und 2 AMG, § 3 AMPreisV) in Folge des Urteils des Gerichtshofs der Europäischen Union vom 19. Oktober 2016 - C-148/15 [ECLI:EU:C:2016:776], Deutsche Parkinson Vereinigung - (NVwZ 2016, 1793) wegen "Inländerdiskriminierung" mit Art. 12 Abs. 1, Art. 3 Abs. 1 GG unvereinbar ist.
Die vorläufige Streitwertfestsetzung für das Revisionsverfahren beruht auf § 47 Abs. 1, § 52 Abs. 2 und § 63 Abs. 1 Satz 1 GKG.